Cargando…

European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadamuro, Janne, Lippi, Giuseppe, von Meyer, Alexander, Ibarz, Mercedes, van Dongen, Edmee, Cornes, Michael, Nybo, Mads, Vermeersch, Pieter, Grankvist, Kjell, Guimaraes, Joao Tiago, Kristensen, Gunn B.B., de la Salle, Barbara, Simundic, Ana-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559623/
https://www.ncbi.nlm.nih.gov/pubmed/31223259
http://dx.doi.org/10.11613/BM.2019.020705
_version_ 1783425831074267136
author Cadamuro, Janne
Lippi, Giuseppe
von Meyer, Alexander
Ibarz, Mercedes
van Dongen, Edmee
Cornes, Michael
Nybo, Mads
Vermeersch, Pieter
Grankvist, Kjell
Guimaraes, Joao Tiago
Kristensen, Gunn B.B.
de la Salle, Barbara
Simundic, Ana-Maria
author_facet Cadamuro, Janne
Lippi, Giuseppe
von Meyer, Alexander
Ibarz, Mercedes
van Dongen, Edmee
Cornes, Michael
Nybo, Mads
Vermeersch, Pieter
Grankvist, Kjell
Guimaraes, Joao Tiago
Kristensen, Gunn B.B.
de la Salle, Barbara
Simundic, Ana-Maria
author_sort Cadamuro, Janne
collection PubMed
description INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. MATERIALS AND METHODS: An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. RESULTS: Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples - monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut-offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. CONCLUSION: Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe.
format Online
Article
Text
id pubmed-6559623
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Croatian Society of Medical Biochemistry and Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-65596232019-06-20 European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) Cadamuro, Janne Lippi, Giuseppe von Meyer, Alexander Ibarz, Mercedes van Dongen, Edmee Cornes, Michael Nybo, Mads Vermeersch, Pieter Grankvist, Kjell Guimaraes, Joao Tiago Kristensen, Gunn B.B. de la Salle, Barbara Simundic, Ana-Maria Biochem Med (Zagreb) Original Articles INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. MATERIALS AND METHODS: An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. RESULTS: Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples - monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut-offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. CONCLUSION: Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe. Croatian Society of Medical Biochemistry and Laboratory Medicine 2019-06-15 2019-06-15 /pmc/articles/PMC6559623/ /pubmed/31223259 http://dx.doi.org/10.11613/BM.2019.020705 Text en ©Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Cadamuro, Janne
Lippi, Giuseppe
von Meyer, Alexander
Ibarz, Mercedes
van Dongen, Edmee
Cornes, Michael
Nybo, Mads
Vermeersch, Pieter
Grankvist, Kjell
Guimaraes, Joao Tiago
Kristensen, Gunn B.B.
de la Salle, Barbara
Simundic, Ana-Maria
European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title_full European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title_fullStr European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title_full_unstemmed European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title_short European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
title_sort european survey on preanalytical sample handling – part 2: practices of european laboratories on monitoring and processing haemolytic, icteric and lipemic samples. on behalf of the european federation of clinical chemistry and laboratory medicine (eflm) working group for the preanalytical phase (wg-pre)
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559623/
https://www.ncbi.nlm.nih.gov/pubmed/31223259
http://dx.doi.org/10.11613/BM.2019.020705
work_keys_str_mv AT cadamurojanne europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT lippigiuseppe europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT vonmeyeralexander europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT ibarzmercedes europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT vandongenedmee europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT cornesmichael europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT nybomads europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT vermeerschpieter europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT grankvistkjell europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT guimaraesjoaotiago europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT kristensengunnbb europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT delasallebarbara europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre
AT simundicanamaria europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre